☰

Laura K. Hilton, Ph.D. - Publications

Affiliations: 
2013 Simon Fraser University, Burnaby, British Columbia, Canada 
Area:
Molecular Biology, Biochemistry
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Benoit A, Abraham MJ, Li S, Kim J, Estrada-Tejedor R, Bakadlag R, Subramaniam N, Makhani K, Guilbert C, Tu R, Salaciak M, Klein KO, Coyle KM, Hilton LK, Santiago R, et al. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment. International Journal of Hematology. PMID 38285120 DOI: 10.1007/s12185-023-03692-x  0.675
2024 Grants JM, May C, Bridgers J, Huang S, Gillis S, Meissner B, Boyle M, Ben-Neriah S, Hung S, Duns G, Hilton L, Gerrie AS, Marra M, Kridel R, Sabatini PJB, et al. Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing. Clinical Chemistry. 70: 273-284. PMID 38175592 DOI: 10.1093/clinchem/hvad147  0.414
2023 Hilton LK, Scott DW, Morin RD. Biological heterogeneity in diffuse large B-cell lymphoma. Seminars in Hematology. PMID 38151380 DOI: 10.1053/j.seminhematol.2023.11.006  0.68
2023 Sircar A, Singh S, Xu-Monette ZY, Coyle KM, Hilton LK, Chavdoula E, Ranganathan P, Jain N, Hanel W, Tsichlis P, Alinari L, Peterson BR, Tao J, Muthusamy N, Baiocchi R, et al. Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia. PMID 37598282 DOI: 10.1038/s41375-023-02006-8  0.592
2023 Davies JR, Hilton LK, Jiang A, Barrans SL, Burton C, Johnson PWM, Davies AJ, Du MQ, Tooze RM, Cucco F, Care MA, Morin RD, Steidl C, Sha C, Westhead DR, et al. Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood Advances. PMID 37595057 DOI: 10.1182/bloodadvances.2023010673  0.506
2023 Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, et al. Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300570. PMID 37319384 DOI: 10.1200/JCO.23.00570  0.81
2023 Dreval K, Hilton LK, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, Collinge BJ, Coyle KM, Duns G, Farinha P, Grande B, Meissner B, Pararajalingam P, Rushton CK, Slack GW, et al. Genetic Subdivisions of Follicular Lymphoma Defined by Distinct Coding and non-coding Mutation Patterns. Blood. PMID 37084389 DOI: 10.1182/blood.2022018719  0.783
2023 Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, et al. Relapse timing is associated with distinct evolutionary dynamics in DLBCL. Medrxiv : the Preprint Server For Health Sciences. PMID 36945587 DOI: 10.1101/2023.03.06.23286584  0.83
2022 Wang X, Nissen M, Gracias D, Kusakabe M, Simkin G, Jiang A, Duns G, Sarkozy C, Hilton L, Chavez EA, Segat GC, Wong R, Kim J, Aoki T, Islam R, et al. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk. Nature Communications. 13: 6772. PMID 36351924 DOI: 10.1038/s41467-022-34408-0  0.648
2022 Alduaij W, Collinge BJ, Ben-Neriah S, Jiang A, Hilton LK, Boyle M, Meissner B, Chong LC, Miyata-Takata T, Slack GW, Farinha P, Craig JW, Lytle A, Savage KJ, Villa D, et al. Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population. Blood. PMID 36302166 DOI: 10.1182/blood.2022018248  0.662
2022 Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, Dreval K, Wong JCH, Vlasevska S, Corinaldesi C, Soni RK, Basso K, Morin RD, Khiabanian H, Pasqualucci L, et al. Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. PMID 36253470 DOI: 10.1038/s41586-022-05285-w  0.611
2022 Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Barta SK, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Cruz M, Dyer M, et al. GENETIC SUBGROUPS INFORM ON PATHOBIOLOGY IN ADULT AND PEDIATRIC BURKITT LYMPHOMA. Blood. PMID 36201743 DOI: 10.1182/blood.2022016534  0.825
2022 Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, Dreval K, Wong JCH, Vlasevska S, Corinaldesi C, Soni RK, Basso K, Morin RD, Khiabanian H, Pasqualucci L, et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. PMID 35794478 DOI: 10.1038/s41586-022-04906-8  0.679
2021 Nowicka M, Hilton LK, Ashton-Key M, Hargreaves CE, Lee C, Foxall R, Carter MJ, Beers SA, Potter KN, Bolen CR, Klein C, Knapp A, Mir F, Rose-Zerilli M, Burton C, et al. Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment. Blood Advances. 5: 2945-2957. PMID 34323958 DOI: 10.1182/bloodadvances.2021004770  0.767
2021 Duns G, ViganĂ² E, Ennishi D, Sarkozy C, Hung SS, Chavez EA, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock B, Slack GW, Hsi ED, Craig JW, Hilton LK, et al. Characterization of DLBCL with a PMBL gene expression signature. Blood. PMID 33684939 DOI: 10.1182/blood.2020007683  0.837
2021 Shanmugam V, Craig JW, Hilton LK, Nguyen MH, Rushton CK, Fahimdanesh K, Lovitch S, Ferland B, Scott DW, Aster JC. Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors. Blood Advances. 5: 71-83. PMID 33570635 DOI: 10.1182/bloodadvances.2020002995  0.811
2020 Jiang A, Hilton LK, Tang J, Rushton CK, Grande BM, Scott DW, Morin RD. PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers. Blood Cancer Discovery. 1: 244-257. PMID 33392514 DOI: 10.1158/2643-3230.BCD-20-0076  0.754
2020 Isaev K, Ennishi D, Hilton L, Skinnider B, Mungall KL, Mungall AJ, Bakhtiari M, Tremblay-LeMay R, Silva A, Ben-Neriah S, Boyle M, Villa D, Marra MA, Steidl C, Gascoyne RD, et al. Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma. Haematologica. PMID 32817292 DOI: 10.3324/Haematol.2020.255950  0.7
2020 Rushton CK, Arthur SE, Alcaide M, Cheung M, Jiang A, Coyle KM, Cleary KLS, Thomas N, Hilton LK, Michaud N, Daigle S, Davidson J, Bushell K, Yu S, Rys RN, et al. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma. Blood Advances. 4: 2886-2898. PMID 32589730 DOI: 10.1182/Bloodadvances.2020001696  0.725
2019 Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, Rushton CK, Boyle M, Meissner B, Scott DW, Morin RD. --The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. PMID 31527075 DOI: 10.1182/Blood.2019002600  0.788
2019 Rushton C, Arthur SE, Alcaide M, Cheung M, Thomas N, Hilton LK, Michaud NR, Daigle S, Davidson J, Bushell KR, Yu S, Jain MD, Shepherd LE, Crump M, Mann KK, et al. Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP Blood. 134: 921-921. DOI: 10.1182/Blood-2019-127399  0.801
2019 Hilton L, Alcaide M, Ben-Neriah S, Jiang A, Grande B, Rushton C, Boyle M, Meissner B, Scott D, Morin R. CRYPTIC MYC AND BCL2 REARRANGEMENTS ARE AMONG A RANGE OF GENETIC MECHANISMS UNDERLYING THE DOUBLE HIT SIGNATURE IN NON-DOUBLE HIT DIFFUSE LARGE B-CELL LYMPHOMA Hematological Oncology. 37: 73-74. DOI: 10.1002/Hon.42_2629  0.805
2018 Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nature Communications. 9: 4001. PMID 30275490 DOI: 10.1038/S41467-018-06354-3  0.734
2016 Hilton LK, Meili F, Buckoll PD, Rodriguez-Pike JC, Choutka CP, Kirschner JA, Warner F, Lethan M, Garces FA, Qi J, Quarmby LM. A Forward Genetic Screen and Whole Genome Sequencing Identify Deflagellation Defective Mutants in Chlamydomonas, Including Assignment of ADF1 as a TRP Channel. G3 (Bethesda, Md.). PMID 27520959 DOI: 10.1534/G3.116.034264  0.693
2013 Hilton LK, Gunawardane K, Kim JW, Schwarz MC, Quarmby LM. The kinases LF4 and CNK2 control ciliary length by feedback regulation of assembly and disassembly rates. Current Biology : Cb. 23: 2208-14. PMID 24184104 DOI: 10.1016/J.Cub.2013.09.038  0.658
2010 Parker JD, Hilton LK, Diener DR, Rasi MQ, Mahjoub MR, Rosenbaum JL, Quarmby LM. Centrioles are freed from cilia by severing prior to mitosis. Cytoskeleton (Hoboken, N.J.). 67: 425-30. PMID 20506243 DOI: 10.1002/Cm.20454  0.741
2009 Hilton LK, White MC, Quarmby LM. The NIMA-related kinase NEK1 cycles through the nucleus. Biochemical and Biophysical Research Communications. 389: 52-6. PMID 19699716 DOI: 10.1016/J.Bbrc.2009.08.086  0.649
Show low-probability matches.